BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33670798)

  • 1. Myocardial Hypertrophy and Compensatory Increase in Systolic Function in a Mouse Model of Oxidative Stress.
    Varshney R; Ranjit R; Chiao YA; Kinter M; Ahn B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular superoxide dismutase protects the heart against oxidative stress and hypertrophy after myocardial infarction.
    van Deel ED; Lu Z; Xu X; Zhu G; Hu X; Oury TD; Bache RJ; Duncker DJ; Chen Y
    Free Radic Biol Med; 2008 Apr; 44(7):1305-13. PubMed ID: 18206658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload.
    Lu Z; Xu X; Hu X; Fassett J; Zhu G; Tao Y; Li J; Huang Y; Zhang P; Zhao B; Chen Y
    Antioxid Redox Signal; 2010 Oct; 13(7):1011-22. PubMed ID: 20406135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.
    Koga K; Kenessey A; Ojamaa K
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H282-93. PubMed ID: 23144312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload.
    Schnelle M; Sawyer I; Anilkumar N; Mohamed BA; Richards DA; Toischer K; Zhang M; Catibog N; Sawyer G; Mongue-Din H; Schröder K; Hasenfuss G; Shah AM
    Cardiovasc Res; 2021 Jan; 117(1):178-187. PubMed ID: 31821410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superoxide scavenging and Akt inhibition in myocardium ameliorate pressure overload-induced NF-κB activation and cardiac hypertrophy.
    Hingtgen SD; Li Z; Kutschke W; Tian X; Sharma RV; Davisson RL
    Physiol Genomics; 2010 Apr; 41(2):127-36. PubMed ID: 20103697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of long-term caloric restriction on myocardial and cardiomyocyte contractile function and autophagy in mice.
    Han X; Turdi S; Hu N; Guo R; Zhang Y; Ren J
    J Nutr Biochem; 2012 Dec; 23(12):1592-9. PubMed ID: 22444502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα.
    Wang X; Chen L; Zhao X; Xiao L; Yi S; Kong Y; Jiang Y; Zhang J
    Cell Death Dis; 2020 Feb; 11(2):96. PubMed ID: 32029708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-binding EGF-like growth factor induces heart interstitial fibrosis via an Akt/mTor/p70s6k pathway.
    Lian H; Ma Y; Feng J; Dong W; Yang Q; Lu D; Zhang L
    PLoS One; 2012; 7(9):e44946. PubMed ID: 22984591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp22 overexpression induces myocardial hypertrophy, senescence and reduced life span through enhanced oxidative stress.
    Morin D; Long R; Panel M; Laure L; Taranu A; Gueguen C; Pons S; Leoni V; Caccia C; Vatner SF; Vatner DE; Qiu H; Depre C; Berdeaux A; Ghaleh B
    Free Radic Biol Med; 2019 Jun; 137():194-200. PubMed ID: 31047988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling.
    Gogiraju R; Hubert A; Fahrer J; Straub BK; Brandt M; Wenzel P; Münzel T; Konstantinides S; Hasenfuss G; Schäfer K
    Circ Heart Fail; 2019 Jan; 12(1):e005622. PubMed ID: 30621510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
    Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
    Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
    Zhang P; Xu X; Hu X; van Deel ED; Zhu G; Chen Y
    Circ Res; 2007 Apr; 100(7):1089-98. PubMed ID: 17363700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nox2 dependent redox-regulation of Akt and ERK1/2 to promote left ventricular hypertrophy in dietary obesity of mice.
    Bhatti SN; Li JM
    Biochem Biophys Res Commun; 2020 Jul; 528(3):506-513. PubMed ID: 32507594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac vulnerability to ischemia/reperfusion injury drastically increases in late pregnancy.
    Li J; Umar S; Iorga A; Youn JY; Wang Y; Regitz-Zagrosek V; Cai H; Eghbali M
    Basic Res Cardiol; 2012 Jul; 107(4):271. PubMed ID: 22648276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy.
    Zou Y; Liang Y; Gong H; Zhou N; Ma H; Guan A; Sun A; Wang P; Niu Y; Jiang H; Takano H; Toko H; Yao A; Takeshima H; Akazawa H; Shiojima I; Wang Y; Komuro I; Ge J
    Hypertension; 2011 Dec; 58(6):1099-110. PubMed ID: 21986507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.